Blue Cross Blue Shield of Massachusetts' Alternative Quality Contract Offers New Contracting Design
|
| Posted
:
Wed, 04 Nov 2009 16:02:39 GMT |
| Author
:
HealthLeaders-InterStudy |
| Category
:
Press Release |
| News Alerts by
Email ( click
here ) |
|
|
|
|
New Report from HealthLeaders-InterStudy Provides Snapshot of Massachusetts' Managed Care and Healthcare Environment NASHVILLE, Tenn., Nov. 4
NASHVILLE, Tenn., Nov. 4 /PRNewswire/ -- HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that Blue Cross Blue Shield of Massachusetts is making a significant change from its traditional fee-for-service contracts with its Alternative Quality Contract. Begun in 2008, the Alternative Quality Contract is intended to combine the best features of capitation and pay-for-performance. The voluntary option includes two forms of payments: a fixed payment per patient, per year, adjusted for the health of the patient, and performance incentives tied to nationally accepted measures of quality, effectiveness and improvement of care.
According to the recent Springfield Market Overview, Hampden County Physician Associates was one of the first providers in Massachusetts to sign a five-year Alternative Quality Contract with Blue Cross Blue Shield of Massachusetts. The five-year contract includes an annual payment adjusted for inflation and for sicker patients, and bonuses based on quality-of-care performance. Hampden County Physician Associates also is working on becoming accredited as a medical home.
"As of July, more than 2,000 physicians were included in the Alternative Quality Contract, demonstrating the increasing uptake of these performance-based initiatives," said Deborah White, market analyst with HealthLeaders-InterStudy. "While discussions around national healthcare reform have a lot of people looking at what's happening in Massachusetts, the outcomes of this Alternative Quality Contract will be closely watched."
Why Pharmaceutical Companies Need Market Overviews
Market Overviews provide a detailed analysis of local healthcare market drivers in 87 of the nation's most dynamic metro areas, allowing pharmaceutical executives to quickly gain local area expertise. Each report provides local-level insights into: health systems and hospitals, physicians, health plans, Medicare/Medicaid, pharmaceutical environment, legislation and employers.
About HealthLeaders-InterStudy
HealthLeaders-InterStudy, a Decision Resources, Inc. company, is the authoritative source for managed care data, analysis and news. For more information, please visit www.HL-ISY.com.
About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.
All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.
For more information, contact:
Lisa Osgood Elizabeth Marshall
HealthLeaders-InterStudy Decision Resources, Inc.
781-296-2606 781-296-2563
losgood@hl-isy.com emarshall@dresources.com
SOURCE HealthLeaders-InterStudy
|
Copyright © 2008
PR Newswire. All rights reserved.
|
|
|
|
|
Related
News
Noah Education Files Form 20-F for Fiscal Year 2009
SHENZHEN, China, Nov. 23 /PRNewswire-Asia-FirstCall/ -- Noah Education
Holdings Ltd. (NYSE: NED) ("Noah" or "the Company"), a leading provider of
interactive educational content and education services in China, tod...
Controversial Award-Winning Film Obsession Available for Free Online Streaming
NEW YORK, Nov. 23 /PRNewswire/ -- The producers of Obsession Radical Islam's War Against the West are making the full-length feature documentary available for online viewing free of charge over Thanksgiving weekend.
The film, whose retail price is $19.95, ...
Victory Pharma, Inc. Announces Launch of NAPRELAN(R) Dose Card
SAN DIEGO, Nov. 23 /PRNewswire/ -- Victory Pharma, Inc. ("Victory") announced today the launch of NAPRELAN® Dose Card, a further extension of Victory's NAPRELAN franchise.
NAPRELAN Dose Card is designed for patients who require relief from mild to moderate pai...
Fragmentation Prevention and Energy Savings BURBANK, CA -- 11/23/09 --
For many years, conservation of energy has been
a serious issue. It traces back to our natural resources such as coal and
water and the amount of carbon being released in to the atmosphere, but it
also has a more practica..
Mediasite by Sonic Foundry Named Best Webcasting/Presentations Solution by Streaming Media Readers
MADISON, Wis., Nov. 23 /PRNewswire/ -- Mediasite by Sonic Foundry, Inc. (Nasdaq: SOFOD), the recognized market leader for rich media webcasting and knowledge management, has been voted Best Webcasting/Presentations Solution in the ...
RXi Pharmaceuticals Wins 2009 RNAi Technology Innovation of the Year Award from Frost & Sullivan WORCESTER, Mass. -
RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical
company pursuing the development and commercialization of proprietary
therapeutics based on RNA interference (RNAi), today reported that the
Company has received Frost & Sullivan’s 2009 North Ame
SciClone Announces Enrollment Completion in Phase 2 Oral Mucositis Trial of SCV-07 FOSTER CITY, CA -- 11/23/09 --
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that patient enrollment is complete ahead of schedule
for its phase 2 trial of SCV-07 -- a small molecule synthetic peptide with
immunomodulating propertie..
|
|
|
|
|
|
|
|
|